LS2 Annual e-Meeting 2021
| Event Start Date | 18 Feb 2021 14:20 |
| Event End Date | 18 Feb 2021 16:20 |
| Location | Virtual Event |
LS2 Intersection Bioinformatics e-Symposium
Precision Medicine and Biomarkers: The Quest for Gold
Chairs and speakers
Chairs:
Mark Ibberson, PhD. Director, Vital-IT Group SIB Swiss Institute of Bioinformatics
Alan Bridge, Director Swiss-Prot group of the SIB Swiss Institute of Bioinformatics
Speakers:
Maria Gomez, Professor of Physiology at the Department of Clinical Sciences in Malmö and Coordinator of LUDC (Lund University Diabetes Centre)
Ewan Pearson, Professor of Diabetic Medicine at the University of Dundee
Precision medicine can be described as treating patients based on their own characteristics (molecular or other) rather than treating everyone with a disease or condition in the same way. Biomarkers are the patient measurements or characteristics which enable health care professionals to build a specific profile for each patient and inform decisions on prognosis or treatment options. The quest for disease biomarkers is increasingly moving away from traditional single blood markers to building predictive or prognostic patient profiles derived from many thousands of readouts such as plasma peptides, lipids or metabolites. The challenge is to find new biomarkers that have an additive or complementary effect compared to established biomarkers and that can be used in the clinic to predict future disease, progression, drug response and complications.
This symposium will explore current approaches for biomarker discovery and precision medicine, addressing clinical, technical and bioinformatics aspects. There will be two invited speakers followed by a series of short talks selected from submitted abstracts.